NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,754
-16.3%
2,5500.0%0.00%
Q2 2023$3,290
-2.3%
2,5500.0%0.00%
Q1 2023$3,366
-12.0%
2,5500.0%0.00%
Q4 2022$3,825
+27.5%
2,5500.0%0.00%
Q3 2022$3,0000.0%2,5500.0%0.00%
Q2 2022$3,000
-62.5%
2,5500.0%0.00%
Q1 2022$8,000
+14.3%
2,5500.0%0.00%
Q4 2021$7,000
-22.2%
2,5500.0%0.00%
Q3 2021$9,000
-18.2%
2,5500.0%0.00%
Q2 2021$11,000
+22.2%
2,5500.0%0.00%
Q1 2021$9,0000.0%2,5500.0%0.00%
Q4 2020$9,000
+50.0%
2,5500.0%0.00%
Q3 2020$6,000
+20.0%
2,5500.0%0.00%
Q2 2020$5,000
+25.0%
2,5500.0%0.00%
Q1 2020$4,000
-20.0%
2,5500.0%0.00%
Q4 2019$5,0000.0%2,5500.0%0.00%
Q3 2019$5,000
-28.6%
2,5500.0%0.00%
Q2 2019$7,0000.0%2,5500.0%0.00%
Q1 2019$7,0002,5500.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders